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Background/aim: This study aimed to investigate the relationship between the iodine concentration (IC) of perigastric fat tissue as
assessed by dual-energy computed tomography (DECT) and serosal invasion of gastric cancer.
Materials and methods: A total of 41 patients underwent preoperative staging evaluation for gastric cancer using DECT between July
2015 and March 2018. Patients were divided into 2 groups based on pathology results: serosal invasion (stage T4a) and intact serosa
(stages T1–T3). Cutoff values, the diagnostic efficacy of IC in the perigastric fat tissue, and the perigastric fat tissue/tumor (P/T) ratio
were determined.
Results: Among the 41 patients, 22 had stage T4a gastric cancer and 19 patients had gastric cancer with a stage lower than T4a. The
mean IC of perigastric fat tissue and the P/T ratio were significantly higher in patients with serosal invasion than in those with intact
serosa (P < 0.001). During the arterial phase, the area under the curve (AUC) was 0.915 and 0.854 for the IC of perigastric fat tissue and
the P/T ratio, respectively. During the venous phase, the AUC was 0.890 and 0.876 for the IC of perigastric fat tissue and the P/T ratio,
respectively.
Conclusion: The IC in the perigastric fat tissue seems to be a reliable indicator for serosal invasion of gastric cancer.
Key words: DECT, gastric cancer, iodine concentration

1. Introduction
Gastric cancer remains one of the most important causes
of cancer-related deaths worldwide (1–3). Early, correct
diagnosis and precise preoperative staging of gastric cancer
are very important because these patients can be treated
with laparoscopic or minimally invasive surgery (4). The
5-year survival rate in patients with early gastric cancer is
85%–100%, whereas that in patients with advanced gastric
cancer is 7%–27% (4). The TNM staging system is usually
used to stage gastric cancer, and T4 is described as a tumor
that has spread through all the muscle layers outside the
stomach and invades the serosa or adjacent structures (3).
Selection of the appropriate treatment options, including
neoadjuvant chemotherapy or multiorgan surgery,
depends on correct differentiation between stage T4
gastric cancer and T3 or earlier stages (5–7).
Computed tomography (CT) is the most common
method used to identify the stages of gastric cancer and
assess the local extension of the tumor, nodal disease, and

metastases with up to 80%–89% accuracy (8). Moreover,
magnetic resonance imaging, endoscopic ultrasonography,
and positron emission tomography can be used in tumor
staging.
Dual-energy CT (DECT) is a newly developed
technology, with the main principle based on the
application of 2 distinct energy settings that can be used
to distinguish materials composed of different molecular
compounds according to their attenuation characteristics
(9,10). DECT can provide material-specific imaging
instead of attenuation-based imaging. For example, the
presence of iodine, calcium, barium, and uric acid in an
image can be obtained with a single examination (9,10).
Additionally, the presence and amount of the targeted
material, such as iodine, can be evaluated in a lesion or an
organ. After DECT images are obtained, multiple datasets,
such as virtually unenhanced images, monochromatic
images, elemental decomposition analyses, and iodinated
attenuation maps can be acquired simultaneously (11).
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Accurate material decomposition from DECT images
can be used to obtain the quantitative iodine concentration
(IC). DECT can contribute to tumor detection, lesion
characterization, and evaluation of the response to
neoadjuvant chemotherapy in oncology patients. A
phantom study showed that the IC calculated from DECT
images indicates the actual IC (12). Furthermore, the IC can
be used as an imaging biomarker to estimate the efficacy of
neoadjuvant chemotherapy in patients with gastric cancer
(13,14).
Therefore, the IC measured from the perigastric
adipose tissue of the lesser and greater omentum may be
used to evaluate the stage of tumor invasion in patients
with gastric cancer. In this study, we aimed to investigate
the relationship between the IC of perigastric fat tissue and
serosal invasion of gastric cancer with histopathological
results as a reference.
2. Materials and methods
2.1. Study population
Between July 2015 and March 2018, 45 patients were
evaluated with preoperative CT and DECT to determine the
stage of gastric cancer, which was confirmed by endoscopic
biopsy. Four patients were excluded from the study due to
an allergy to the contrast medium (n = 1), oral contrast
agent administration (n = 1), or known stage T4b cancer
(n = 2). Therefore, 41 patients were included in the study. A
final diagnosis was obtained based on the histopathologic
analysis of resected specimens after surgery. The patients’
CT images were reevaluated by 2 radiologists who were
blinded to the endoscopic findings and pathological results
until a consensus was reached. The patients’ demographic
characteristics were recorded. Patients were divided into 2
groups based on postoperative pathological results: serosal
invasion (stage T4a) and intact serosa (stages T1–T3). The
study was approved by the institutional ethics committee,
and written informed consent was obtained from all
patients before DECT examination.
2.2. CT protocol
All CT examinations were performed using a 160-slice dualenergy CT scanner (Toshiba Aquilion; Toshiba Medical
Systems, Otawara, Japan). All patients fasted for at least 8
h before the CT examination and drank 500–1000 mL of
water to expand the stomach just before CT examination.
DECT images were obtained at 25 s and 70 s after
administration of nonionic contrast agent (arterial phase
and portal venous phase, respectively) to each patient based
on their weight (2 mL/kg) and 30 mL of saline injection at
a flow rate of 4 mL/s. The arterial and portal venous phase
images were obtained using dual-energy scan mode with
a tube voltage of 80 kVp and 130 kVp with a tin filter, a
tube current of 230 and 150 mAs, a collimation of 32 × 0.6
mm for both tubes, a pitch of 0.55, and a gantry rotation

time of 0.5 s. The images were reconstructed with a 1.5-mm
thickness. Moreover, the images were reconstructed with a
5-mm slice thickness to measure the IC during the arterial
and portal venous phases.
2.3. Analysis of CT and DECT images
Monochromatic arterial and venous phase images were
acquired by combining high- and low-energy images at
a 1:1 ratio. These images were considered as simulated
single-energy 120-kVp images for analyzing the
diagnostic performance of CT to detect serosal invasion
of gastric cancer. Image analysis and measurements were
reevaluated using the standard dual-energy software on
the CT console (Version 6, Toshiba Medical Systems). The
arterial and venous phase images derived from high- and
low-energy images were both reconstructed with 5-mm
slice thickness. First, the region of interest (ROI) was
placed on the normal gastric wall and the tumor tissue,
and then the ROI was positioned on perigastric fat tissue
close to the tumor to measure the IC in the involved gastric
serosa (Figure 1). A circular or elliptical ROI measuring
25–50 mm2 (avoiding vascular structures) was used. All
measurements were performed at least 3 times, and the
average values were recorded. Moreover, the ICs during
the arterial and venous phases were calculated repeatedly.
An ROI of the same size and shape was placed at the same
anatomic location.
2.4. Statistical analysis
All of the data were analyzed using SPSS 13.0 (SPSS Inc.,
Chicago, IL, USA) and the MedCalc package (MedCalc
Statistical Software version 16.8, MedCalc Software bvba,
Ostend, Belgium). The means and ranges of age and the ICs
of the tumor, perigastric fat tissue, and normal gastric wall
were calculated. Additionally, the IC of the perigastric fat
tissue/tumor ratio (P/T) was noted during the arterial and
portal venous phases. The Kolmogorov–Smirnov test was
used to evaluate deviation from the normal distribution.
The parametric Student t-test was used to compare the ICs
of the tumor, perigastric fat tissue, and normal gastric wall.
The optimal cutoff points for the ICs for the determination
of serosal invasion of gastric cancer were found using
receiver operating characteristic (ROC) curve analysis. If
the obtained IC was less than the given cutoff value, the
patient was considered to have no serosal invasion. If
the obtained IC was greater than the given cutoff value,
the patient was considered to have serosal invasion. The
sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), and accuracy of these
parameters were calculated. Furthermore, the diagnostic
performance of the CT evaluation was noted. The area
under the fitted binormal ROC curve (AUC) was used
to measure the diagnostic efficacy. The AUC values were
calculated and compared using these parameters. P < 0.05
was considered to indicate significant difference.
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Figure 1. Representative CT images obtained from a 58-year-old female patient with adenocarcinoma with invasion of serosa. (A)
The mixed venous phase image shows thickening of the wall of the antrum with transmural enhancement. (B) The iodine shows that
the iodine concentrations were 74.7 mg/mL in the perigastric fat (ROI 1), 116.3 mg/mL in the tumor (ROI 2), and 54.5 mg/mL in the
normal gastric wall (ROI 3).

3. Results
In the present study, 41 patients (31 male, 10 female;
age range: 30–89 years; mean age: 63 years) underwent
preoperative abdominal DECT for gastric cancer staging.
According to the postoperative pathology results, 19
patients had gastric cancer of less than stage T4a with
intact serosa, and 22 patients had stage T4a gastric cancer
with serosal invasion. The histopathologic diagnoses were
13 well-differentiated adenocarcinomas, 15 moderately
differentiated adenocarcinomas, 7 poorly differentiated
adenocarcinomas, 5 mucinous adenocarcinomas, and 1
signet ring cell carcinoma. The locations of the gastric
tumors were the antrum in 13 patients, the lesser curvature
in 11 patients, the greater curvature in 8 patients, the
cardia in 5 patients, and the corpus in 4 patients.
Based on images obtained using conventional CT,
17 of 19 patients were classified as having gastric cancer
of less than stage T4a with intact serosa, and 16 of 22
patients were correctly diagnosed with stage T4a gastric
cancer during arterial phase imaging. Moreover, 17 of 19
patients were classified as having gastric cancer below
stage T4a with intact serosa, and 17 of 22 patients were
correctly diagnosed with stage T4a gastric cancer during
venous phase imaging. The accuracies of conventional
CT were 0.809 and 0.829 during the arterial and venous
phases, respectively.
Table 1 shows the mean ICs of the tumor, perigastric
fat tissue, and normal gastric wall and the P/T ratio.
During the arterial phase, the mean ICs of the tumor,
perigastric fat tissue, and normal gastric wall and the P/T
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ratio were 75.8 mg/mL, 57.0 mg/mL, 45.4 mg/mL, and
0.83, respectively. During the portal venous phase, the
mean ICs of the tumor, perigastric fat tissue, and normal
gastric wall and the P/T ratio were 92.1 mg/mL, 66.2
mg/mL, 54.4 mg/mL, and 0.77, respectively. The mean
IC in the perigastric fat tissue and the T/P ratio were
significantly higher in patients with serosal invasion than
in those without serosal invasion (P < 0.001) (Figure 2).
However, the differences in the mean ICs of the tumor
and the normal gastric wall between patients with and
those without serosal invasion were not significant.
For arterial and portal venous phase imaging, the
ROC curves for the IC of the perigastric fat tissue and
the P/T ratio are shown in Figure 3. The AUCs were 0.915
and 0.854 for the IC of the perigastric fat tissue and the
P/T ratio, respectively. The optimal cutoff values obtained
from the ROC curve analysis that provided the highest
sensitivity and specificity for the IC of the perigastric
fat tissue and the P/T ratio were 56 mg/mL and 0.71,
respectively. The diagnostic values obtained with these
cutoff values are presented in Table 2. The AUCs were
0.890 and 0.876 for the IC of the perigastric fat tissue
and the P/T ratio, respectively. The optimal cutoff values
obtained from the ROC analysis that provided the highest
sensitivity and specificity for the IC of the perigastric
fat tissue and the P/T ratio were 60 mg/mL and 0.68,
respectively. The AUCs for the IC of the perigastric
fat tissue and the T/P ratio did not show significant
differences during the arterial and portal venous phases
(P > 0.692).

KÜPELİ et al. / Turk J Med Sci
Table 1. Patient characteristics.

Total

Serosal invasion

P-value

Present

Absent

41

22

19

IC values of tumor (mg/mL)

75.8 ± 23.7

73.1 ± 24.3

78.8 ± 23.2

0.445

Normal gastric wall (mg/mL)

45.4 ± 15.9

45.7 ± 15.9

45.0± 16.4

0.917

IC values of PFT (mg/mL)

57.0 ± 17.3

68.3 ± 13.0

44.0 ± 11.6

<0.001

P/T ratio

0.83 ± 0.4

1.04 ± 0.42

0.59 ± 0.18

<0.001

IC values of tumor (mg/mL)

92.1 ± 28.8

88.7 ± 27.9

96.1 ± 23.2

0.425

Normal gastric wall (mg/mL)

54.4± 16.6

54.5± 18.6

54.4 ± 14.4

0.875

IC values of PFT (mg/mL)

66.2 ± 21.1

79.1 ± 17.2

51.4 ± 14.1

<0.001

P/T ratio

0.77 ± 0.3

0.95 ± 0.29

0.57 ± 0.18

<0.001

Number
Arterial phase

Venous phase

PFT: Perigastric fat tissue; P/T: perigastric fat tissue/tumor.

4. Discussion
In this present prospective study, we investigated the role
of the IC measured from perigastric adipose tissue for
evaluating serosal invasion of gastric cancer. Our results
showed that the IC of the perigastric fat tissue and the P/T
ratio could be used to evaluate serosal invasion of gastric
cancer during the arterial and portal venous phases. The
IC of the perigastric fat tissue and the P/T ratio had 87.8%
and 73.1% accuracy, respectively, during the arterial phase
and 85.3% and 80.5% accuracy, respectively, during the
portal venous phase for determining serosal invasion of
gastric cancer.
Clinically, DECT has improved tumor detection and
staging by reducing the scan time and radiation dose during
oncological examination. Iodine measurements made with
DECT are a quantitative imaging method for the advanced
assessment of tumors with iodine uptake (15). With the
increasing clinical use of DECT, this imaging modality
has been implemented for various whole-body routine
oncological monitoring, as in gastric cancer (16). In this
study, patients with serosal invasion of gastric cancer had a
significantly higher IC in the perigastric fat tissue adjacent
to the tumor during both the arterial and portal venous
phases than those without tumor invasion. Additionally,
Yang et al. showed that ICs were significantly higher in
patients with serosal invasion due to gastric cancer than
in those without serosal invasion (16). When the tumor
spreads to the serosa, stromal reactions, such as increased
fibroblasts, inflammatory and immune cells, proliferating
vessels, and noncellular matrix components, play
important roles in cancer progression (17). The higher IC
in the perigastric fat tissue of patients with serosal invasion

is probably related to increased perfusion, possibly due to
proliferating vessels induced by tumor invasion or leakage
from malignant cell membranes.
Chemotherapy or chemoradiotherapy can be performed
preoperatively in patients with resectable tumors or those
with nodal metastasis. On CT images, increased density
of fat tissues at the serosal surface is commonly used to
define serosal invasion of gastric cancer, whereas reactive
fibrous connective tissue hyperplasia in the serosa may
also lead to increased density (16). Although thin-slice CT
images, multiplanar reformation techniques, and virtual
gastroscopy can effectively assess the extent of gastric
cancer, the specificity of CT imaging for detecting serosal
invasion remains relatively low (18–21). In our study, 3
and 4 patients had stage T4a lesions diagnosed during
the arterial and venous phases, respectively, that were
underestimated as lesions that were below stage T4a. These
findings show the limitations of using CT for detecting
serosal invasion of gastric cancer.
The accuracy of CT in staging gastric cancer has
been reported to be approximately 80%–89% (8,18–
21). Consistent with previous studies, we obtained
approximately 80% accuracy of CT for detecting serosal
invasion of gastric cancer. Additionally, this study revealed
that ICs obtained with DECT may be promising for defining
stage T4a gastric cancer with diagnostic performance
similar to that of multiplanar images. However, IC still
cannot be used to detect serosal invasion in all patients.
In our study, 19 of 22 patients with serosal invasion were
correctly classified using DECT. Approximately 80%
sensitivity and 85% specificity were found during the
arterial and venous phases; however, ICs alone were not
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Figure 2. Representative CT images obtained from a 41-year-old male patient with adenocarcinoma without invasion of serosa with
transmural enhancement. (A) The mixed arterial phase image shows thickening of the wall of the antrum. (B) The iodine shows that the
iodine concentrations were 17.5 mg/mL in the perigastric fat (ROI 1), 91.6 mg/mL in the tumor (ROI 2), and 62.5 mg/mL in the normal
gastric wall (ROI 3). (C) The histological image with hematoxylin and eosin (HE, 100×) shows stage T3 adenocarcinoma (black arrow)
without invasion of surrounding submucosa (white arrow).

suitable for differentiating these patients. ICs as calculated
by DECT can contribute to the use of single-energy CT for
the diagnosis of stage T4a gastric cancer.
DECT provides both quantitative and qualitative data.
Iodine maps are color maps; better color distinction can
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be obtained with iodine maps than with grayscale images
obtained with a conventional multidetector CT scanner.
Additionally, ICs obtained from DECT are numerical
data; thus, objective diagnosis and evaluation can be
performed. Increased perfusion due to abnormal tumor
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Figure 3. The graph shows the receiver operating characteristic curve for the
iodine concentration (IC) values of perigastric fat tissue (PFT) and perigastric
fat tissue/tumor (P/T) ratio in the arterial phase (AP) and venous phase (VP).
Table 2. Results of receiver operating characteristic (ROC) analysis for IC values of PFT and P/T ratio.
AUC

Cutoff Level Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

Accuracy (%)

Arterial phase
IC values of PFT

0.915

56 (mg/mL) 86.3

89.4

90.5

85.0

87.8

P/T ratio

0.854

0.71

73.6

77.3

73.7

73.1

77.2

Venous phase
IC values of PFT

0.890

60 (mg/mL) 81.8

89.4

90.0

81.0

85.3

P/T ratio

0.876

0.68

78.9

81.8

78.9

80.4

81.8

AUC: Area under the curve; PPV: positive predictive value; NPV: negative predictive value; PFT: perigastric fat tissue; P/T: perigastric
fat tissue/tumor.

angiogenesis occurs in areas invaded by cancer cells.
The IC in the serosal fat tissue could be used to evaluate
increased perfusion. Therefore, ICs obtained with DECT
may show more objective and accurate diagnostic
performance for detecting serosal invasion of gastric
cancer than other parameters. Furthermore, DECT
can facilitate detection of tumor invasion of adjacent
vascular structures with the use of monochromatic
images (22,23).
This study has a number of limitations. First, we
did not evaluate the inter- or intraobserver variability

in the study. The second limitation is that there were
not enough patients to investigate the effectiveness of
ICs for differentiating subtypes of gastric cancer. The
third limitation is that normalized iodine values were
not evaluated. The fourth limitation is that benign and
malignant lymph node staging was not performed.
In conclusion, the IC measured in the perigastric
fat tissue seems to be a reliable technique for detecting
serosal invasion of gastric cancer. However, extensive
studies with larger populations are needed to clearly
confirm the effectiveness of this method.
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